Avantor Inc
General ticker "AVTR" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $14.6B
Avantor Inc follows the US Stock Market performance with the rate: 8.5%.
Estimated limits based on current volatility of 1.7%: low 20.79$, high 21.53$
Factors to consider:
- US accounted for 53.2% of revenue in the fiscal year ended 2023-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [16.56$, 26.14$]
- 2024-12-30 to 2025-12-30 estimated range: [18.83$, 28.91$]
Financial Metrics affecting the AVTR estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.07
- Positive: -0.96 < Investing cash flow per share, $ of -0.21
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 2.42
- Negative: Industry earnings per price (median), % of -3.50 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
Short-term AVTR quotes
Long-term AVTR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $7,386.10MM | $7,512.40MM | $6,967.20MM |
| Operating Expenses | $6,413.90MM | $6,382.20MM | $6,270.80MM |
| Operating Income | $972.20MM | $1,130.20MM | $696.40MM |
| Non-Operating Income | $-219.20MM | $-279.10MM | $-285.90MM |
| Interest Expense | $217.40MM | $265.80MM | $284.80MM |
| Income(Loss) | $753.00MM | $851.10MM | $410.50MM |
| Taxes | $180.40MM | $164.60MM | $89.40MM |
| Profit(Loss) | $572.60MM | $686.50MM | $321.10MM |
| Stockholders Equity | $4,197.00MM | $4,855.40MM | $5,252.60MM |
| Inventory | $872.00MM | $913.50MM | $828.10MM |
| Assets | $13,897.20MM | $13,464.30MM | $12,972.70MM |
| Operating Cash Flow | $953.60MM | $843.60MM | $870.00MM |
| Capital expenditure | $111.10MM | $133.40MM | $146.40MM |
| Investing Cash Flow | $-4,121.70MM | $-109.60MM | $-143.70MM |
| Financing Cash Flow | $3,219.20MM | $-648.70MM | $-843.70MM |
| Earnings Per Share* | $0.86 | $1.02 | $0.48 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.